2m 2m 2m 2m 2m 2m 2m
TARSUS PHARMA (TARS)
NASDAQ
$77.98+$1.21 (+1.58%)
Price as of Nov 12, 2026 8:58 AM EST- $3.8BMarket Cap
- 2.61%1-Year Change
- BiotechnologyIndustry
TARSUS PHARMA (TARS)
$77.98+$1.21 (+1.58%)
TARS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $76.76 | ||
Change | +$2.93 (+3.97%) | ||
Open | $73.53 | ||
High | $77.47 | ||
Low | $73.53 | ||
Previous Close | $73.83 | ||
Volume | 749,308 | ||
30-Day Average Volume | 1,083,426 | ||
1-Week Change | 11.13% | ||
1-Month Change | 4.92% | ||
1-Year Change | 2.61% | ||
3-Year Change | 339.38% | ||
5-Year Change | 179.23% | ||
Fundamentals | |||
Shares Outstanding | 49.3M | ||
Total Assets | $505.5M | ||
Market Cap | $3.8B | ||
Enterprise Value | $3.7B | ||
Period: QTR TTM FY | |||
Revenue | $194.6M | ||
Net Income | -$668.3M | ||
Free Cash Flow | -$7.2M | ||
EBIT | -$661.5M | ||
EBITDA | -$661.3M | ||
Net Working Capital | $218.3M | ||
EPS | -$14.40 | ||
Enterprise Value/EBITDA | -6 | ||
Enterprise Value/Revenue | 19 | ||
P/B | 36 | ||
P/E | -5 | ||
PEG | 0 | ||
Price/Free Cash Flow | -525 | ||
Price/Operating Cash Flow | -631 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue